痴呆
发表于 2025-3-26 23:03:55
http://reply.papertrans.cn/24/2313/231284/231284_31.png
BRAVE
发表于 2025-3-27 04:31:52
http://reply.papertrans.cn/24/2313/231284/231284_32.png
grotto
发表于 2025-3-27 06:28:52
Evaluation of the Blood Compatibility of Materials, Cells, and Tissues: Basic Concepts, Test Modelsluation of the biocompatibility of materials and therapeutic cells and tissues. The use of different anticoagulants and specific inhibitors in order to be able to dissect interactions between the different cascade systems and cells of the blood is discussed. In addition, we describe two clinically r
Directed
发表于 2025-3-27 11:01:03
http://reply.papertrans.cn/24/2313/231284/231284_34.png
TAP
发表于 2025-3-27 16:54:21
0065-2598 ve treatment approaches and potent drug candidates have recently emerged and are currently evaluated in disease models and clinical trials.. .The chapters in this book cover a wide range of topics related to th978-1-4899-7823-3978-1-4614-4118-2Series ISSN 0065-2598 Series E-ISSN 2214-8019
异端
发表于 2025-3-27 19:44:03
Book 2013ight and the marketing of the first complement-targeted drugs, a plethora of highly creative treatment approaches and potent drug candidates have recently emerged and are currently evaluated in disease models and clinical trials.. .The chapters in this book cover a wide range of topics related to th
STANT
发表于 2025-3-28 00:06:22
Defective Complement Action and Control Defines Disease Pathology for Retinal and Renal Disorders a
hypnotic
发表于 2025-3-28 04:15:57
0065-2598 earch and showcases methods developed and perfected in the l.This book highlights progress and trends in the rapidly evolving field of complement-related drug discovery and spotlights examples of clinical applications. As an integral part of innate immunity and critical mediator in homeostatic and i
硬化
发表于 2025-3-28 06:51:23
http://reply.papertrans.cn/24/2313/231284/231284_39.png
躺下残杀
发表于 2025-3-28 13:29:11
Complement-Targeted Therapeutics in Periodontitis,s of the various complement components and pathways in periodontitis have only recently started to be elucidated. In this chapter, we review recent progress in the field and discuss the potential of complement-targeted therapeutics in the treatment of periodontitis.